Cargando…
Pingyangmycin inhibits glycosaminoglycan sulphation in both cancer cells and tumour tissues
Pingyangmycin is a clinically used anticancer drug and induces lung fibrosis in certain cancer patients. We previously reported that the negatively charged cell surface glycosaminoglycans are involved in the cellular uptake of the positively charged pingyangmycin. However, it is unknown if pingyangm...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7131950/ https://www.ncbi.nlm.nih.gov/pubmed/32068946 http://dx.doi.org/10.1111/jcmm.15017 |
_version_ | 1783517350626066432 |
---|---|
author | Lan, Ying Li, Xiulian Liu, Yong He, Yanli Hao, Cui Wang, Hua Jin, Liying Zhang, Guoqing Zhang, Shufeng Zhou, Aimin Zhang, Lijuan |
author_facet | Lan, Ying Li, Xiulian Liu, Yong He, Yanli Hao, Cui Wang, Hua Jin, Liying Zhang, Guoqing Zhang, Shufeng Zhou, Aimin Zhang, Lijuan |
author_sort | Lan, Ying |
collection | PubMed |
description | Pingyangmycin is a clinically used anticancer drug and induces lung fibrosis in certain cancer patients. We previously reported that the negatively charged cell surface glycosaminoglycans are involved in the cellular uptake of the positively charged pingyangmycin. However, it is unknown if pingyangmycin affects glycosaminoglycan structures. Seven cell lines and a Lewis lung carcinoma‐injected C57BL/6 mouse model were used to understand the cytotoxicity of pingyangmycin and its effect on glycosaminoglycan biosynthesis. Stable isotope labelling coupled with LC/MS method was used to quantify glycosaminoglycan disaccharide compositions from pingyangmycin‐treated and untreated cell and tumour samples. Pingyangmycin reduced both chondroitin sulphate and heparan sulphate sulphation in cancer cells and in tumours. The effect was persistent at different pingyangmycin concentrations and at different exposure times. Moreover, the cytotoxicity of pingyangmycin was decreased in the presence of soluble glycosaminoglycans, in the glycosaminoglycan‐deficient cell line CHO745, and in the presence of chlorate. A flow cytometry‐based cell surface FGF/FGFR/glycosaminoglycan binding assay also showed that pingyangmycin changed cell surface glycosaminoglycan structures. Changes in the structures of glycosaminoglycans may be related to fibrosis induced by pingyangmycin in certain cancer patients. |
format | Online Article Text |
id | pubmed-7131950 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71319502020-04-06 Pingyangmycin inhibits glycosaminoglycan sulphation in both cancer cells and tumour tissues Lan, Ying Li, Xiulian Liu, Yong He, Yanli Hao, Cui Wang, Hua Jin, Liying Zhang, Guoqing Zhang, Shufeng Zhou, Aimin Zhang, Lijuan J Cell Mol Med Original Articles Pingyangmycin is a clinically used anticancer drug and induces lung fibrosis in certain cancer patients. We previously reported that the negatively charged cell surface glycosaminoglycans are involved in the cellular uptake of the positively charged pingyangmycin. However, it is unknown if pingyangmycin affects glycosaminoglycan structures. Seven cell lines and a Lewis lung carcinoma‐injected C57BL/6 mouse model were used to understand the cytotoxicity of pingyangmycin and its effect on glycosaminoglycan biosynthesis. Stable isotope labelling coupled with LC/MS method was used to quantify glycosaminoglycan disaccharide compositions from pingyangmycin‐treated and untreated cell and tumour samples. Pingyangmycin reduced both chondroitin sulphate and heparan sulphate sulphation in cancer cells and in tumours. The effect was persistent at different pingyangmycin concentrations and at different exposure times. Moreover, the cytotoxicity of pingyangmycin was decreased in the presence of soluble glycosaminoglycans, in the glycosaminoglycan‐deficient cell line CHO745, and in the presence of chlorate. A flow cytometry‐based cell surface FGF/FGFR/glycosaminoglycan binding assay also showed that pingyangmycin changed cell surface glycosaminoglycan structures. Changes in the structures of glycosaminoglycans may be related to fibrosis induced by pingyangmycin in certain cancer patients. John Wiley and Sons Inc. 2020-02-18 2020-03 /pmc/articles/PMC7131950/ /pubmed/32068946 http://dx.doi.org/10.1111/jcmm.15017 Text en © 2020 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Articles Lan, Ying Li, Xiulian Liu, Yong He, Yanli Hao, Cui Wang, Hua Jin, Liying Zhang, Guoqing Zhang, Shufeng Zhou, Aimin Zhang, Lijuan Pingyangmycin inhibits glycosaminoglycan sulphation in both cancer cells and tumour tissues |
title | Pingyangmycin inhibits glycosaminoglycan sulphation in both cancer cells and tumour tissues |
title_full | Pingyangmycin inhibits glycosaminoglycan sulphation in both cancer cells and tumour tissues |
title_fullStr | Pingyangmycin inhibits glycosaminoglycan sulphation in both cancer cells and tumour tissues |
title_full_unstemmed | Pingyangmycin inhibits glycosaminoglycan sulphation in both cancer cells and tumour tissues |
title_short | Pingyangmycin inhibits glycosaminoglycan sulphation in both cancer cells and tumour tissues |
title_sort | pingyangmycin inhibits glycosaminoglycan sulphation in both cancer cells and tumour tissues |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7131950/ https://www.ncbi.nlm.nih.gov/pubmed/32068946 http://dx.doi.org/10.1111/jcmm.15017 |
work_keys_str_mv | AT lanying pingyangmycininhibitsglycosaminoglycansulphationinbothcancercellsandtumourtissues AT lixiulian pingyangmycininhibitsglycosaminoglycansulphationinbothcancercellsandtumourtissues AT liuyong pingyangmycininhibitsglycosaminoglycansulphationinbothcancercellsandtumourtissues AT heyanli pingyangmycininhibitsglycosaminoglycansulphationinbothcancercellsandtumourtissues AT haocui pingyangmycininhibitsglycosaminoglycansulphationinbothcancercellsandtumourtissues AT wanghua pingyangmycininhibitsglycosaminoglycansulphationinbothcancercellsandtumourtissues AT jinliying pingyangmycininhibitsglycosaminoglycansulphationinbothcancercellsandtumourtissues AT zhangguoqing pingyangmycininhibitsglycosaminoglycansulphationinbothcancercellsandtumourtissues AT zhangshufeng pingyangmycininhibitsglycosaminoglycansulphationinbothcancercellsandtumourtissues AT zhouaimin pingyangmycininhibitsglycosaminoglycansulphationinbothcancercellsandtumourtissues AT zhanglijuan pingyangmycininhibitsglycosaminoglycansulphationinbothcancercellsandtumourtissues |